By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RHEI Pharmaceuticals, Inc. 

Corporate Headquarters
300 George Street, Suite 530
New Haven  Connecticut  06511-6624  U.S.A.
Phone: 203-624-RHEI Fax: 203-624-7433



Company News
RHEI Pharmaceuticals, Inc. Gaining on SFDA Approval of MuGard(TM) 6/17/2011 10:00:07 AM
RHEI Pharmaceuticals, Inc. to Market Oral Mucositis Treatment in China 9/30/2010 12:06:34 PM
Access Pharmaceuticals (ACCP) Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals, Inc. 9/21/2010 7:17:32 AM
Skinvisible, Inc. (SKVI) Signs DermSafe Agreement For Europe and China - RHEI Pharmaceuticals, Inc. Adds Alcohol-Free Hand Sanitizer to its Product Line 7/20/2010 2:34:25 PM
Skinvisible, Inc. (SKVI) Licenses Invisicare Products for U.S., China and Europe 7/13/2010 10:22:11 AM
RHEI Pharmaceuticals, Inc. Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China 12/8/2008 7:56:55 AM
RHEI Pharmaceuticals, Inc. Elects Mrs. Zheng Hong to Board of Directors 11/20/2008 11:46:32 AM
RHEI Pharmaceuticals, Inc. Appoints Dr. Geert Cauwenbergh as Chief Executive Officer 8/26/2008 7:04:32 AM
RHEI Pharmaceuticals, Inc. Licenses Attental From MethaPharma for Distribution Throughout Asia 2/19/2008 6:51:26 AM
Access Pharmaceuticals (ACCP) Outlicenses China Rights for Mucositis Product to RHEI Pharmaceuticals, Inc. 1/14/2008 2:53:29 PM